Remove approval-supplement-deck-reata-dives-launch-its-first-commercial-product-skyclarys
article thumbnail

With approval supplement on deck, Reata dives into launch of its first commercial product Skyclarys

Fierce Pharma

With a spring approval in hand, Reata Pharmaceuticals has been waiting patiently to launch its first commercial product, Skyclarys. million sales target for 2023.

FDA 228